Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Accumulated Expenses (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Accumulated Expenses for 16 consecutive years, with $11.5 million as the latest value for Q3 2025.

  • Quarterly Accumulated Expenses rose 68.99% to $11.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $11.5 million through Sep 2025, up 68.99% year-over-year, with the annual reading at $5.6 million for FY2024, 46.59% down from the prior year.
  • Accumulated Expenses for Q3 2025 was $11.5 million at Xtant Medical Holdings, up from $6.8 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $11.5 million in Q3 2025, with the low at $3.0 million in Q3 2021.
  • Average Accumulated Expenses over 5 years is $6.1 million, with a median of $5.6 million recorded in 2024.
  • The sharpest move saw Accumulated Expenses soared 133.4% in 2023, then crashed 46.59% in 2024.
  • Over 5 years, Accumulated Expenses stood at $4.3 million in 2021, then grew by 2.64% to $4.5 million in 2022, then skyrocketed by 133.4% to $10.4 million in 2023, then plummeted by 46.59% to $5.6 million in 2024, then soared by 107.28% to $11.5 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $11.5 million, $6.8 million, and $6.3 million for Q3 2025, Q2 2025, and Q1 2025 respectively.